Skip to Content
Merck
CN
  • Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells.

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells.

Oncotarget (2017-10-04)
Haojun Xiong, Yan Zhang, Shan Chen, Zhenhong Ni, Jintao He, Xinzhe Li, Bo Li, Kai Zhao, Fan Yang, Yijun Zeng, Bingbo Chen, Fengtian He
ABSTRACT

Liver X receptor (LXR), a member of nuclear receptor superfamily, is involved in the regulation of glucose, lipid and cholesterol metabolism. Recently, it has been reported that LXR suppress different kinds of cancers including hepatocellular carcinoma (HCC). However, the corresponding mechanism is still not well elucidated. In the present study, we found that activation of LXR downregulated cyclin D1 while upregulated p21 and p27 by elevating the level of suppressor of cytokine signaling 3 (SOCS3), leading to the cell cycle arrest at G1/S phase and growth inhibition of HCC cells. Moreover, we demonstrated that LXRα (not LXRβ) mediated the induction of SOCS3 in HCC cells. Subsequently, we showed that LXR activation enhanced the mRNA stability of SOCS3, but had no significant influence on the transcriptional activity of

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
GW4064, ≥97% (HPLC)
Sigma-Aldrich
GW3965 hydrochloride, ≥98% (HPLC), powder